Clinical Trials Browser

Phase 2 × Not yet recruiting × balstilimab × Clear all

NCT07516366 2026-04-13

Testing the Safety and Feasibility of Immunotherapy Drugs, Botensilimab and Balstilimab, Before Surgery for Clear Cell Renal Cell Carcinoma, NEO RoBOT Trial

Phase 2 Not yet recruiting

Carcinoma, Renal Cell